{"name":"Inventage Lab., Inc.","slug":"inventage-lab-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Vivitrol Injectable Product","genericName":"Vivitrol Injectable Product","slug":"vivitrol-injectable-product","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Vivitrol Injectable Product","genericName":"Vivitrol Injectable Product","slug":"vivitrol-injectable-product","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQNWNCNGx6dFJObm1HN3M0Ym9XbjVBcTFOdWJvcnFKVUxIdm5JSXRUMFJBczNwT0FXeTBKVHBadFJ2SXJ2T25maUhzWGFqWmRONWhGaGNGYkx2eEJLSVREQllsVjFwdmxqNmlWUV8tTWlrQm5XSk96NHg0dTBhdXhyd3IzVQ?oc=5","date":"2025-11-24","type":"pipeline","source":"팜이데일리","summary":"Big pharma interest lifts Inventage Lab·D&D Pharmatech to 52-week highs[K-Bio Pulse] - 팜이데일리","headline":"Big pharma interest lifts Inventage Lab·D&D Pharmatech to 52-week highs[K-Bio Pulse] - 팜이데일리","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBoeDNwalV2MUVURHhBcXVTYjNZenZzQ1lpdzQ4ZmtlcXAyd050Ni0zUGFPdmpWWGNPT2kxLUY4clo5X2FET0h6UDB6eTRkaE9Na1dIWDlQbzY1SW41UmdxcjY4SHk5N2hGdVJseUVR?oc=5","date":"2024-01-05","type":"pipeline","source":"KED Global","summary":"Inventage Lab, Yuhan to co-work for obesity treatment - KED Global","headline":"Inventage Lab, Yuhan to co-work for obesity treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFB1djFKYTJoSWoyRVl2VjZFNkhOUXBFZWJBSXRFYVMtX0lmQWFBeUhJMERualBMRVdEQTJ1MkF2UGFJb1Q2aEYzVktqc2FjY2lzSFJMbWJZZFdISmNmRmVoSS1wc0l3ZHE4dUNXeTNB?oc=5","date":"2023-01-26","type":"trial","source":"KED Global","summary":"Inventage Lab launches clinical trials for addiction treatment in Australia - KED Global","headline":"Inventage Lab launches clinical trials for addiction treatment in Australia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE95eDBJRWRBUE9NWm1jYVZKMkNvWFY3VjRGNFBUZER0LUVQQ0dIRVlUOXRqTnpndTFnbHIxUXVOS0NYZ2ZHb29LNHdDaEJydW56elhtMWR0YWRhZ2Y0ak11enA4VnE2eUxGelpMX9IBcEFVX3lxTE1hZG44cWhrTnFUcUdvZ3Vndlc4OG9JZUdCQzl2cDRkclJpeHFQUkxsNkt4MEt6RGhBSm9FU2ZzbnhYSjdTSEZXaFV6ZGQ4SFZobFBZQWdVMTJZQ2t5TU1mOWJSUVpLczM3OGt2TkRHZFE?oc=5","date":"2020-05-25","type":"deal","source":"koreabiomed.com","summary":"Daewoong partners with Inventage Lab for long-acting drug - koreabiomed.com","headline":"Daewoong partners with Inventage Lab for long-acting drug","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}